Benzinga's Top Upgrades, Downgrades For December 24, 2019

Loading...
Loading...

Downgrades

  • B. Riley downgraded AquaVenture Holdings Limited WAAS from Buy to Neutral. AquaVenture shares closed at $27.10 on Monday.
  • Argus Research downgraded FedEx Corporation FDX from Buy to Hold. FedEx shares closed at $151.69 on Monday.
  • Jefferies downgraded Wright Medical Group N.V. WMGI from Buy to Hold. Wright Medical shares closed at $30.26 on Monday.
  • Raymond James downgraded AquaVenture Holdings WAAS from Outperform to Market Perform. AquaVenture shares closed at $27.10 on Monday.
  • RBC Capital downgraded AquaVenture Holdings Limited WAAS from Outperform to Sector Perform. AquaVenture shares closed at $27.10 on Monday.
  • Lake Street downgraded AquaVenture Holdings Limited WAAS from Buy to Hold. AquaVenture shares closed at $27.10 on Monday.


Initiations

  • Oppenheimer initiated coverage on MannKind Corporation MNKD with an Outperform rating. MannKind closed at $1.31 on Monday.
  • Analysts at Raymond James initiated coverage on Amgen Inc. AMGN with a Market Perform rating. Amgen shares closed at $243.03 on Monday.
  • JP Morgan initiated coverage on Y-mAbs Therapeutics, Inc. YMAB with an Overweight rating. The price target for Y-mAbs Therapeutics is set to $39. Y-mAbs Therapeutics shares closed at $32.42 on Monday.
  • Analysts at Cantor Fitzgerald initiated coverage on Stemline Therapeutics, Inc. STML with an Overweight rating. The price target for Stemline Therapeutics is set to $18. Stemline Therapeutics shares closed at $10.77 on Monday.
  • Analysts at Raymond James initiated coverage on Regeneron Pharmaceuticals, Inc. REGN with a Market Perform rating. Regeneron Pharmaceuticals shares closed at $374.20 on Monday.
  • JP Morgan initiated coverage on Kodiak Sciences Inc. KOD with an Overweight rating. The price target for Kodiak Sciences is set to $82. Kodiak Sciences shares closed at $66.10 on Monday.
  • Analysts at Oppenheimer initiated coverage on Otonomy, Inc. OTIC with a Outperform rating. The price target for Otonomy is set to $8. Otonomy shares closed at $2.55 on Monday.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsInitiationstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...